Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Name: Bain Capital Life Sciences Investors, LLC Q3 2020 13F Filing | 13F Explorer
Creator: Bain Capital Life Sciences Investors, LLC
Published: 2020-11-16

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $1.073B (100.0% shares, 0.0% debt)

Holdings (22)

— SPRINGWORKS THERAPEUTICS INC 32.4%

Value $347M Shares 7,281,307 Est. Cost $21.68 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS, INC. 10.9%

Value $117M Shares 3,979,292 Est. Cost $26.87 Unrealized -0.6%

ANNX ANNEXON INC 9.1%

Value $97.99M Shares 3,241,628 Est. Cost $23.46 Unrealized 0.0%

— DICERNA PHARMACEUTICALS INC 6.8%

Value $73.4M Shares 4,080,237 Est. Cost $9.03 Unrealized —

— MERSANA THERAPEUTICS, INC. 6.0%

Value $64.16M Shares 3,445,667 Est. Cost $23.40 Unrealized —

REPL REPLIMUNE GROUP INC 4.6%

Value $48.86M Shares 2,122,415 Est. Cost $17.53 Unrealized +30.0%

— DYNAVAX TECHNOLOGIES CORP. 4.4%

Value $47.07M Shares 10,895,773 Est. Cost $4.63 Unrealized —

NRIX NURIX THERAPEUTICS, INC. 4.2%

Value $44.84M Shares 1,284,314 Est. Cost $25.20 Unrealized 0.0%

— SAGE THERAPEUTICS, INC. 2.8%

Value $30.5M Shares 499,100 Est. Cost $41.58 Unrealized —

— CONSTELLATION PHARMACEUTICALS INC. 2.6%

Value $28.36M Shares 1,400,000 Est. Cost $47.11 Unrealized —

KYMR KYMERA THERAPEUTICS INC. 2.2%

Value $23.57M Shares 729,606 Est. Cost $30.53 Unrealized 0.0%

SVRA SAVARA INC 2.1%

Value $22.98M Shares 5,128,593 Est. Cost $1.20 Unrealized +42.1%

— AEGLEA BIOTHERAPEUTICS, INC. 1.8%

Value $19.14M Shares 2,700,000 Est. Cost $9.25 Unrealized —

— APTINYX INC 1.8%

Value $18.79M Shares 5,558,425 Est. Cost $10.97 Unrealized —

— MARINUS PHARMACEUTICALS INC 1.7%

Value $18.39M Shares 1,431,059 Est. Cost $6.30 Unrealized —

CRNX CRINETICS PHARMACEUTICALS, INC. 1.6%

Value $16.79M Shares 1,071,428 Est. Cost $17.05 Unrealized -10.3%

— THERAPEUTICS ACQUISITION COR 1.3%

Value $14.38M Shares 1,000,000 Est. Cost $14.38 Unrealized —

— X4 PHARMACEUTICALS INC 1.0%

Value $11.16M Shares 1,648,485 Est. Cost $10.70 Unrealized —

— ARYA SCIENCES ACQUISITION CORP III 1.0%

Value $10.81M Shares 1,000,000 Est. Cost $10.81 Unrealized —

— SOLID BIOSCIENCES INC 0.7%

Value $7.858M Shares 3,871,164 Est. Cost $8.88 Unrealized —

— BCTG ACQUISITION CORP 0.5%

Value $5.18M Shares 500,000 Est. Cost $10.36 Unrealized —

— PANACEA ACQUISITION CORP 0.5%

Value $5M Shares 500,000 Est. Cost $10.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	7,281,307	$347M	32.4%	$21.68	—	COM	85205L107
ARQT	ARCUTIS BIOTHERAPEUTICS, INC.	3,979,292	$117M	10.9%	$26.87	-0.6%	COM	03969K108
ANNX	ANNEXON INC	3,241,628	$97.99M	9.1%	$23.46	0.0%	COM	03589W102
—	DICERNA PHARMACEUTICALS INC	4,080,237	$73.4M	6.8%	$9.03	—	COM	253031108
—	MERSANA THERAPEUTICS, INC.	3,445,667	$64.16M	6.0%	$23.40	—	COM	59045L106
REPL	REPLIMUNE GROUP INC	2,122,415	$48.86M	4.6%	$17.53	+30.0%	COM	76029N106
—	DYNAVAX TECHNOLOGIES CORP.	10,895,773	$47.07M	4.4%	$4.63	—	COM	268158201
NRIX	NURIX THERAPEUTICS, INC.	1,284,314	$44.84M	4.2%	$25.20	0.0%	COM	67080M103
—	SAGE THERAPEUTICS, INC.	499,100	$30.5M	2.8%	$41.58	—	COM	78667J108
—	CONSTELLATION PHARMACEUTICALS INC.	1,400,000	$28.36M	2.6%	$47.11	—	COM	210373106
KYMR	KYMERA THERAPEUTICS INC.	729,606	$23.57M	2.2%	$30.53	0.0%	COM	501575104
SVRA	SAVARA INC	5,128,593	$22.98M	2.1%	$1.20	+42.1%	COM	805111101
—	AEGLEA BIOTHERAPEUTICS, INC.	2,700,000	$19.14M	1.8%	$9.25	—	COM	00773J103
—	APTINYX INC	5,558,425	$18.79M	1.8%	$10.97	—	COM	03836N103
—	MARINUS PHARMACEUTICALS INC	1,431,059	$18.39M	1.7%	$6.30	—	COM	56854Q101
CRNX	CRINETICS PHARMACEUTICALS, INC.	1,071,428	$16.79M	1.6%	$17.05	-10.3%	COM	22663K107
—	THERAPEUTICS ACQUISITION COR	1,000,000	$14.38M	1.3%	$14.38	—	COM CL A	88339T103
—	X4 PHARMACEUTICALS INC	1,648,485	$11.16M	1.0%	$10.70	—	COM	98420X103
—	ARYA SCIENCES ACQUISITION CORP III	1,000,000	$10.81M	1.0%	$10.81	—	COM CL A	G3166W106
—	SOLID BIOSCIENCES INC	3,871,164	$7.858M	0.7%	$8.88	—	COM	83422E105
—	BCTG ACQUISITION CORP	500,000	$5.18M	0.5%	$10.36	—	COM	05492W103
—	PANACEA ACQUISITION CORP	500,000	$5M	0.5%	$10.00	—	UNIT 99/99/9999	698102209